Oncolytics Biotech® Scientist Selected to Participate in the Society of Immunotherapy of Cancer’s (SITC) METIOR … – Marketwired (press release)
|
Oncolytics Biotech® Scientist Selected to Participate in the Society of Immunotherapy of Cancer's (SITC) METIOR …
Marketwired (press release) CALGARY, AB and SAN DIEGO, CA–(Marketwired – March 20, 2018) – Oncolytics Biotech® Inc. (TSX: ONC) ( OTCQX : ONCYF), a biotech company developing REOLYSIN® (pelareorep), an intravenously delivered immuno-oncolytic virus creating an inflamed phenotype … |
